Gabapentin Capsule
Product Images NDC 50090-7675

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This text provides information on the mean pain scores for different treatments over a period of time. It includes details about the baseline, weeks, and different treatment options such as placebo and Gabapentin at a dosage of 3600 mg/day. The text suggests a comparison between a titrated dose of Parkod and a fixed dose approach over a 4-week period.*

FDA Label Image

Figure 2 (Image 02)

This description presents a comparison between the effects of a placebo and different doses of Gabapentin (1800 mg/day and 2400 mg/day) on weekly pain scores. The study spans over seven weeks, showing how the pain scores change from baseline through the different treatment options.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

This text appears to be a chart showing different doses in milligrams (mg) on the x-axis and their corresponding percentages on the y-axis. The chart seems to indicate the daily dosage for something, but without further context, it is not clear what specifically the doses refer to.*

FDA Label Image

Label Image (Lbl500907675)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.